Briefcases -- All Litigations -- INCRETIN MIMETICS MDL2542
INCRETIN MIMETICS MDL2542
Case Files
News
Easy Button
Committees

Categories

Sort by:
  1. Incretin Mimetics Products Liability Litigation MDL Court
  2. Incretin Mimetics Defendants Summary Judgement Motion
  3. Incretin Mimetics Summary Judgement Motion Plaintiffs Response and Counter
  4. Order Granting Defendants Summary Judgement Motion
  5. Incretin Mimetics Products Liability Litigation MDL
  6. Incretin Mimetics Products Liability Litigation MDL 2452 Documents
  7. APPEAL INCRETIN-BASED THERAPIES PRODUCTS LIABILITY LITIGATION SUMMARY JUDGEMENT
View All

Documents

Sort by:
  1. Doc 1539 Order Granting Summary Judgement Motion.pdf
  2. Doc No 206 Master Consolidated Complaint.pdf
  3. 410 Defendant Summary Judgement Motion Notice.pdf
  4. 410-1 Defendants Memo of Points and Authorities.pdf
  5. 410-2 Declaration In Support of Defendants Motion.pdf
  6. 410-3 Defendants Exhibit A Article from NEJM.pdf
  7. 410-4 Defendants Exhibit B Letter from the FDA.pdf
  8. 410-5 Defendants Exhibit C Article for American Diabetes Association.pdf
  9. 410-6 Defendants Exhibit D-F Various FDA Letters.pdf
  10. 410-7 Defendants Exhibit G-I Various FDA Letters.pdf
  11. 410-8 Defendants Exihibit J-L Various FDA Letters.pdf
  12. 410-9 Defendant Exhibit M-O FDA Letter.pdf
  13. 410-10 Defendants Exibit P-R FDA Documents.pdf
  14. 410-11 Defendants Exhibit S Document from EMA.pdf
  15. 410-12 Defendants Exhibit T Clinical Study.pdf
  16. 410-13 Defendants Exhibit U AACE Consensus Statement.pdf
  17. Doc 1539 Order Granting Summary Judgement Motion.pdf
  18. Doc 1573 Order Directing Clerk to Enter Judgement.pdf
  19. Doc 1578 Order Direct Clerk to Enter Judgement.pdf
  20. Doc 1579 Order Directing Clerk to Enter Summary Judgement.pdf
  21. Doc 1166 Notice of Summary Judgement Motion.pdf
  22. 1166-1 Memo of Points and Authorities In Support of Plaintiffs' Motion for Summary.pdf
  23. 1166-2 Declaration In Support of Plaintiffs' Motion for Summary Judgment.pdf
  24. 1166-3 Exhibit 1 - Egan Article.pdf
  25. 1166-4 Exhibit 2 - FDAs April 27, 2015 Letter to Merck.pdf
  26. 1166-5 Exhibit 3 - Filed Under Seal.pdf
  27. 1166-6 Exhibit 4 - FDAs Letter to Public Citizen dated March 25, 2014.pdf
  28. 1166-7 Exhibit 5 - FDAs Guidance for Industry Adverse Reactions Section of Labeling.pdf
  29. 1166-8 Exhibit 6 - FDAs Guidance for Industry Safety Labeling Changes-.pdf
  30. 1166-9 Exhibit 7 - Filed Under Seal.pdf
  31. 1166-10 Exhibit 8 - FDAs Drug Safety Communication.pdf
  32. 1166-11 Exhibit 9 - FDAs Guidance for Industry Warnings and Precautions, Contraindicati.pdf
  33. 1166-12 Exhibit 10 - Filed Under Seal.pdf
  34. 1166-13 Exhibit 11 - Filed Under Seal.pdf
  35. 1166-14 Exhibit 12 - Filed Under Seal.pdf
  36. 1166-15 Exhibit 13 - Filed Under Seal.pdf
  37. 1166-16 Exhibit 14 - Filed Under Seal.pdf
  38. 1166-17 Exhibit 15 - Filed Under Seal.pdf
  39. 1166-18 Exhibit 16 - Pharmacology Review(s) for the Byetta NDA, dated August 28, 2008.pdf
  40. 1166-19 Exhibit 17 - Filed Under Seal.pdf
  41. 1166-20 Exhibit 18 - Filed Under Seal.pdf
  42. 1166-21 Exhibit 19 - Vrang 2012 Study.pdf
  43. 1166-22 Exhibit 20 - Filed Under Seal.pdf
  44. 1166-23 Exhibit 21 - Filed Under Seal.pdf
  45. 1166-24 Exhibit 22 - FDAs Guidance on Drug Safety Information.pdf
  46. 1166-25 Exhibit 23 - Filed Under Seal.pdf
  47. 1166-26 Exhibit 24 - Filed Under Seal.pdf
  48. 1596 Motion for Attorneys Fees Summary Judgement.pdf
  49. 1596-1 Declaration
  50. 1596-1 Memo of Points and Authorities
  51. 1596-2 Memo in Support of Motion for Costs
  52. 1596-3 Proof of Service.pdf
  53. Recent Activity-View All Documents from the past 60 days.pdf
  54. Full Docket Sheet.pdf
  55. Doc No 4 Information regarding pro hac vice applications and association of local counsel.pdf
  56. Doc 157 Order Appointing Plaintiffs' Steering Committee.pdf
  57. Doc. No. 184 Order regarding procedures for direct filing in the MDL.pdf
  58. Doc. No 204-Order governing filing of the Master Consolidated Complaint, Short Form Complaint, and Master Consolidated Answer.pdf
  59. Doc No 208 Short Form Complaint.pdf
  60. Doc No 237 Defendant Merck Sharp & Dohme Corp.'s Answer.pdf
  61. Doc No 238 Defendant Eli Lilly and Company's Answer.pdf
  62. Doc No 240 Defendant Novo Nordisk Inc.'s Answer.pdf
  63. Doc No 241 Amylin Pharmaceutical, LLC's Answer.pdf
  64. Doc No 274 Order following Third Status Conference.pdf
  65. Doc No 276 Order regarding service of process and application of Master Consolidated Complaint.pdf
  66. Doc No 325 Initial Case Management Scheduling Order.pdf
  67. Doc No 349 Order Following Second Case Management Conference.pdf
  68. Doc No 469 Order Following May 28, 2014 Case Management Conference.pdf
  69. DocNo472 Order Denying Defendants' Motion-Summary Judgment-Preemption & Granting Plaintiffs' Rule 56dRequest for Additional Discovery.pdf
  70. Doc No 504 Order Following July 1, 2014 Case Management Conference.pdf
  71. Doc No 563 Order Granting Motion Related to Filing by Derivative Plaintiffs Acting as Interim Estate Representatives.pdf
  72. Doc No 565 Order Concerning Claims of Privilege and Privilege Logs.pdf
  73. Doc No 567 Order Following August 14, 2014 Case Management Conference.pdf
  74. Doc No 568 Order Setting Discovery Dispute Protocol.pdf
  75. Doc No 649 Order Following September 16, 2014 Case Management Conference.pdf
  76. 1505 Summons Issued re 1504.pdf
  77. 1507 SHORT FORM COMPLAINT with Jury Demand against Merck Sharp & Dohme Corp., filed by Margaret Boatwright.pdf
  78. 1509 WAIVER OF SERVICE Returned Executed by Eli Lilly & Company, as to Eli Lilly & Company. (Hamilton, Matthew).pdf
  79. 1510 WAIVER OF SERVICE Returned Executed by Eli Lilly & Company, as to Eli Lilly & Company. (Hamilton, Matthew).pdf
  80. 1511 WAIVER OF SERVICE Returned Executed by Eli Lilly & Company, as to Eli Lilly & Company. (Hamilton, Matthew).pdf
  81. 1512 SHORT FORM COMPLAINT with Jury Demand against Merck Sharp & Dohme Corp Novo Nordisk Inc filed by Larry Short.pdf
  82. 1514 SHORT FORM COMPLAINT with Jury Demand against Merck Sharp & Dohme Corp., filed by James Stempek.pdf
  83. 1515 Summons Issued re 1507.pdf
  84. 1516 Summons Issued re 1512.pdf
  85. 1517 Smmons Issued re 1514.pdf
  86. 1521 SHORT FORM COMPLAINT with Jury Demand against Merck Sharp & Dohme Corp., filed by Joanna Sweet..pdf
  87. 1523 SHORT FORM COMPLAINT with Jury Demand against Amylin Pharmaceuticals, LLC, Eli Lilly and Company, filed by Rita Love.pdf
  88. 1524 Summons Issued re 1521.pdf
  89. 1525 Summons Issued re 1523.pdf
  90. 1526 WAIVER OF SERVICE Returned Executed by Eli Lilly and Company, as to Eli Lilly and Company. (Hamilton, Matthew).pdf
  91. 1527 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  92. 1528 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  93. 1529 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  94. 1530 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  95. 1531WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  96. 1532 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  97. 1533 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  98. 1534 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  99. 1537 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  100. 1540 WAIVER OF SERVICE Returned Executed by Amylin Pharmaceuticals, LLC, as to Amylin Pharmaceuticals, LLC. (Laurendeau, Amy).pdf
  101. 1541 WAIVER OF SERVICE Returned Executed by Amylin Pharmaceuticals, LLC, as to Amylin Pharmaceuticals, LLC. (Laurendeau, Amy).pdf
  102. 1542 WAIVER OF SERVICE Returned Executed by Amylin Pharmaceuticals, LLC.pdf
  103. 1543 WAIVER OF SERVICE Returned Executed by Amylin Pharmaceuticals, LLC, as to Amylin Pharmaceuticals, LLC. (Laurendeau, Amy).pdf
  104. 1545 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  105. 1546 WAIVER OF SERVICE Returned Executed by Merck Sharp & Dohme Corp., as to Merck Sharp & Dohme Corp.. (Pistilli, Emily).pdf
  106. 1551 SHORT FORM COMPLAINT with Jury Demand against Merck Sharp & Dohme Corp., filed by Stella Sennet-Minick.pdf
  107. 1552 SHORT FORM COMPLAINT with Jury Demand against Merck Sharp & Dohme Corp., filed by Frank Tetto.pdf
  108. 1555 SHORT FORM COMPLAINT with Jury Demand against Merck Sharp & Dohme Corp., filed by Edward McKinnon..pdf
  109. 1563 Summons Issued re 1551.pdf
  110. 1564 Summons Issued re 1552.pdf
  111. 1562 Summons Issued re 1547.pdf
  112. 1565 Summons Issued re 1554.pdf
  113. 1571 AMENDED COMPLAINT with Jury Demand against Merck Sharp & Dohme Corp., filed by Frecia Sicilia, Mark Sicilia.....pdf
  114. 1593 BILL OF COSTS submitted by Defendant Merck Sharp & Dohme Corp. in the amount of $87,556.32 etc...pdf
  115. 1594 BILL OF COSTS submitted by Defendant Amylin Pharmaceuticals, LLC in the amount of 163,210.72 etc...pdf
  116. Appeal INCRETIN-BASED THERAPIES PRODUCTS LIABILITY LITIGATION Summary Judgement .pdf
View All